SCHEMBL5899475

SCHEMBL5899475

O=C(CNS(=O)(=O)Cc1cccc([N+](=O)[O-])c1)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.53
RAB9A P51151 2/20 0.52
MAPT P10636 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
GAA P10253 2/20 0.51
HPGD P15428 2/20 0.51
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
HTT P42858 3/20 0.48
HSP90AA1 P07900 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
S1PR2 O95136 1/20 0.48
OPRK1 P41145 1/20 0.48
MITF O75030 1/20 0.48
TP53 P04637 1/20 0.48
LMNA P02545 1/20 0.47
AGTR1 P30556 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1937924 0.81 CYP19A1 (0.58) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL23014272 0.81 KMT2A (0.64) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL5320468 0.81 MMP1 (0.56) ALDH1A1RAB9AMAPTSMN1; SMN2GAA
SCHEMBL1938386 0.79 HPGD (0.55) ALDH1A1RAB9AMAPTSMN1; SMN2HPGD
SCHEMBL5899423 0.79 AKR1C3 (0.49) ALDH1A1SMN1; SMN2HPGDMEN1KMT2A
SCHEMBL11698130 0.78 TP53 (0.58) ALDH1A1RAB9AMAPTSMN1; SMN2HPGD
SCHEMBL4426596 0.78 KMT2A (0.51) ALDH1A1MAPTSMN1; SMN2GAAHPGD
SCHEMBL4432418 0.77 CYP1A2 (0.56) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL5489641 0.77 TSHR (0.56) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL14861394 0.76 CYP1A2 (0.49) ALDH1A1MAPTSMN1; SMN2GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 ALDH1A1 139/4885RAB9A 3734/4885MAPT 3655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.